Allergen-induced, eotaxin-rich, proangiogenic bone marrow progenitors: a blood-borne cellular envoy for lung eosinophilia.

[1]  N. Ferrara.  Vascular Endothelial Growth Factor , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[2]  J. Pearson.  Endothelial progenitor cells – hype or hope? , 2009, Journal of thrombosis and haemostasis : JTH.

[3]  K. Hirschi,et al.  Assessing identity, phenotype, and fate of endothelial progenitor cells. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[4]  S. Rafii,et al.  Endothelial progenitor cells are cellular hubs essential for neoangiogenesis of certain aggressive adenocarcinomas and metastatic transition but not adenomas , 2008, Proceedings of the National Academy of Sciences.

[5]  L. Zentilin,et al.  Bone marrow cells recruited through the neuropilin-1 receptor promote arterial formation at the sites of adult neoangiogenesis in mice. , 2008, The Journal of clinical investigation.

[6]  D. Collen,et al.  Sustained Endothelial Progenitor Cell Dysfunction After Chronic Hypoxia‐Induced Pulmonary Hypertension , 2008, Stem cells.

[7]  D. Celermajer,et al.  Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. , 2008, Journal of the American College of Cardiology.

[8]  G. Lip,et al.  New insights on endothelial progenitor cell subpopulations and their angiogenic properties. , 2008, Journal of the American College of Cardiology.

[9]  M. Gawaz,et al.  Platelet-Derived Stromal Cell–Derived Factor-1 Regulates Adhesion and Promotes Differentiation of Human CD34+ Cells to Endothelial Progenitor Cells , 2008, Circulation.

[10]  T. Colby,et al.  Coexpression of IL-5 and Eotaxin-2 in Mice Creates an Eosinophil-Dependent Model of Respiratory Inflammation with Characteristics of Severe Asthma1 , 2007, The Journal of Immunology.

[11]  M. Yoder,et al.  Working hypothesis to redefine endothelial progenitor cells , 2007, Leukemia.

[12]  James J. Lee,et al.  Eosinophils and asthma , 2007, Current allergy and asthma reports.

[13]  S. Erzurum,et al.  Th1- and Th2-Dependent Endothelial Progenitor Cell Recruitment and Angiogenic Switch in Asthma1 , 2007, The Journal of Immunology.

[14]  Michael I Dorrell,et al.  Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. , 2006, The Journal of clinical investigation.

[15]  L. Hassman,et al.  A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation , 2006, Proceedings of the National Academy of Sciences.

[16]  S. Verma,et al.  Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. , 2006, The Journal of clinical investigation.

[17]  Fan Zhang,et al.  Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes , 2006, Nature Medicine.

[18]  N. Lukacs,et al.  A closer look at chemokines and their role in asthmatic responses. , 2006, European journal of pharmacology.

[19]  B. Aronow,et al.  Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. , 2006, The Journal of clinical investigation.

[20]  Y. Yoon,et al.  Functional disruption of α4 integrin mobilizes bone marrow–derived endothelial progenitors and augments ischemic neovascularization , 2006, The Journal of experimental medicine.

[21]  M. Rothenberg,et al.  The eosinophil. , 2006, Annual review of immunology.

[22]  S. Peters,et al.  Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. , 2005, The Journal of allergy and clinical immunology.

[23]  E. Chavakis,et al.  Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells , 2005, The Journal of experimental medicine.

[24]  Nikolaos M. Nikolaidis,et al.  Identification of a Cooperative Mechanism Involving Interleukin-13 and Eotaxin-2 in Experimental Allergic Lung Inflammation* , 2005, Journal of Biological Chemistry.

[25]  E. Chavakis,et al.  Role of (cid:1) 2-integrins for homing and neovascularization capacity of endothelial progenitor cells , 2004 .

[26]  M. Boothby,et al.  Susceptibility to allergic lung disease regulated by recall responses of dual-receptor memory T cells. , 2004, The Journal of allergy and clinical immunology.

[27]  R. Homer,et al.  Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung , 2004, Nature Medicine.

[28]  E. Lenkiewicz,et al.  Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils , 2004, Science.

[29]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[30]  O. Bakke,et al.  Rapid chemokine secretion from endothelial cells originates from 2 distinct compartments. , 2004, Blood.

[31]  M. Boothby,et al.  Recall helper T cell response: T helper 1 cell-resistant allergic susceptibility without biasing uncommitted CD4 T cells. , 2004, American journal of respiratory and critical care medicine.

[32]  Stefanie Dimmeler,et al.  Relevance of Monocytic Features for Neovascularization Capacity of Circulating Endothelial Progenitor Cells , 2003, Circulation.

[33]  A. Quyyumi,et al.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. , 2003, The New England journal of medicine.

[34]  K. Ohta,et al.  Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells. , 2003, Cellular immunology.

[35]  James J. Lee,et al.  Ablation of eosinophils leads to a reduction of allergen-induced pulmonary pathology. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[36]  Brigit VanGraafeiland,et al.  National Asthma Education and Prevention Program. , 2002, The Nurse practitioner.

[37]  G Salvato,et al.  Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects , 2001, Thorax.

[38]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[39]  J. Isner,et al.  Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. , 2000, Circulation research.

[40]  R. Djukanović,et al.  Bronchial angiogenesis in severe glucocorticoid-dependent asthma. , 2000, The European respiratory journal.

[41]  M. Humbert,et al.  Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. , 1999, Journal of immunology.

[42]  M. Rothenberg,et al.  Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues. , 1999, American journal of respiratory cell and molecular biology.

[43]  R. Coffman,et al.  Depletion of eosinophils in mice through the use of antibodies specific for C‐C chemokine receptor 3 (CCR3) , 1999, Journal of leukocyte biology.

[44]  R. Strieter,et al.  Temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia. , 1998, Journal of immunology.

[45]  D. Carrasco,et al.  Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine eotaxin. , 1998, Blood.

[46]  A. Bellini,et al.  Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation , 1998, Clinical and experimental immunology.

[47]  C. Martínez-A,et al.  The Coordinated Action of CC Chemokines in the Lung Orchestrates Allergic Inflammation and Airway Hyperresponsiveness , 1998, The Journal of experimental medicine.

[48]  S. Rankin,et al.  Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. , 1998, Blood.

[49]  C. Mackay,et al.  Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial and endothelial cells , 1997, European journal of immunology.

[50]  S. Rankin,et al.  Kinetics of Eotaxin Generation and Its Relationship to Eosinophil Accumulation in Allergic Airways Disease: Analysis in a Guinea Pig Model In Vivo , 1997, The Journal of experimental medicine.

[51]  J. Wilson,et al.  Increased vascularity of the bronchial mucosa in mild asthma. , 1997, American journal of respiratory and critical care medicine.

[52]  P. Foster,et al.  Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. , 1997, The Journal of clinical investigation.

[53]  P. Leder,et al.  Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia , 1997, The Journal of experimental medicine.

[54]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[55]  J. Norgauer,et al.  Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. , 1996, Blood.

[56]  P. Leder,et al.  Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia , 1996, Nature Medicine.

[57]  W Newman,et al.  Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. , 1996, The Journal of clinical investigation.

[58]  N. Copeland,et al.  Mouse Eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. , 1996, Immunity.

[59]  J. Hsuan,et al.  Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation , 1994, The Journal of experimental medicine.

[60]  P. Paré,et al.  Small airways dimensions in asthma and in chronic obstructive pulmonary disease. , 1993, The American review of respiratory disease.

[61]  M. Dunnill.  THE PATHOLOGY OF ASTHMA, WITH SPECIAL REFERENCE TO CHANGES IN THE BRONCHIAL MUCOSA , 1960, Journal of clinical pathology.